BR0315888A - Métodos para a preparação de oxazolidinonas n-ariladas via uma reação de acoplamento cruzada catalisada por cobre - Google Patents

Métodos para a preparação de oxazolidinonas n-ariladas via uma reação de acoplamento cruzada catalisada por cobre

Info

Publication number
BR0315888A
BR0315888A BR0315888-8A BR0315888A BR0315888A BR 0315888 A BR0315888 A BR 0315888A BR 0315888 A BR0315888 A BR 0315888A BR 0315888 A BR0315888 A BR 0315888A
Authority
BR
Brazil
Prior art keywords
arylated
preparing
methods
coupling reaction
oxazolidinones
Prior art date
Application number
BR0315888-8A
Other languages
English (en)
Inventor
Stephane Caron
Arun Ghosh
Janice Ethel Sieser
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0315888A publication Critical patent/BR0315888A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/02—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms not condensed with other rings
    • C07D291/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

"MéTODOS PARA A PREPARAçãO DE OXAZOLIDINONAS N-ARILADAS VIA UMA REAçãO DE ACOPLAMENTO CRUZADO CATALISADA POR COBRE". A presente invenção refere-se a métodos para a preparação de compostos de oxazolidinona N-arilados via uma reação de acoplamento cruzado catalisada por cobre.
BR0315888-8A 2002-11-01 2003-10-22 Métodos para a preparação de oxazolidinonas n-ariladas via uma reação de acoplamento cruzada catalisada por cobre BR0315888A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42332802P 2002-11-01 2002-11-01
US10/645,779 US7223870B2 (en) 2002-11-01 2003-08-21 Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
PCT/IB2003/004708 WO2004039788A1 (en) 2002-11-01 2003-10-22 Methods for preparing n-arylated oxazolidinones via a copper catalyzed cross coupling reaction

Publications (1)

Publication Number Publication Date
BR0315888A true BR0315888A (pt) 2005-10-04

Family

ID=32233544

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315888-8A BR0315888A (pt) 2002-11-01 2003-10-22 Métodos para a preparação de oxazolidinonas n-ariladas via uma reação de acoplamento cruzada catalisada por cobre

Country Status (10)

Country Link
US (2) US7223870B2 (pt)
EP (1) EP1562916A1 (pt)
JP (1) JP2006514983A (pt)
AR (1) AR041878A1 (pt)
AU (1) AU2003269414A1 (pt)
BR (1) BR0315888A (pt)
CA (1) CA2501314A1 (pt)
MX (1) MXPA05004661A (pt)
TW (1) TW200420547A (pt)
WO (1) WO2004039788A1 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003269399A1 (en) * 2002-11-01 2004-05-25 Pfizer Products Inc. Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination
TW200831080A (en) * 2006-12-15 2008-08-01 Irm Llc Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
KR101999300B1 (ko) 2007-03-12 2019-07-12 인트라-셀룰라 써래피스, 인코퍼레이티드. 치환된 헤테로환 융합 감마-카르볼린 합성
EP2033957A1 (en) * 2007-09-06 2009-03-11 SOLVAY (Société Anonyme) Process for the manufacture of alkyl compounds
KR101674146B1 (ko) 2008-10-10 2016-11-08 머크 샤프 앤드 돔 코포레이션 옥사졸리디논 및 이를 포함하는 조성물을 제조하는 방법
MX342326B (es) 2011-09-27 2016-09-26 Novartis Ag 3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante.
UY34632A (es) 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
WO2013155506A1 (en) 2012-04-14 2013-10-17 Intra-Cellular Therapies, Inc. Novel compositions and methods
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
MX355945B (es) 2013-03-14 2018-05-07 Novartis Ag 3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante.
ES2846823T3 (es) 2013-03-15 2021-07-29 Intra Cellular Therapies Inc Compuestos orgánicos
AU2014360452C1 (en) 2013-12-03 2019-05-16 Intra-Cellular Therapies, Inc. Novel methods
BR112016023162B1 (pt) 2014-04-04 2022-11-29 Intra-Cellular Therapies, Inc Compostos orgânicos gama-carbolinas, composições farmacêuticas compreendendo os ditos compostos e uso dos mesmos no tratamento ou na profilaxia de transtornos de sistema nervoso central
CN106456638A (zh) 2014-04-04 2017-02-22 细胞内治疗公司 有机化合物
PE20170682A1 (es) 2014-08-04 2017-06-15 Nuevolution As Derivados de pirimidina sustituidos con heterociclilo opcionalmente condensados utiles para el tratamiento de enfermedades inflamatorias, metabolicas, oncologicas y autoinmunitarias
CN104327007B (zh) * 2014-10-20 2016-07-27 安徽师范大学 3,4,5-三取代噁唑烷酮类化合物及其制备方法
CN105153059B (zh) * 2015-09-11 2018-03-06 苏州大学 一种噁唑烷酮化合物的制备方法
PL3838274T3 (pl) 2016-01-26 2024-04-02 Intra-Cellular Therapies, Inc. Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN
EP3888656A1 (en) 2016-03-25 2021-10-06 Intra-Cellular Therapies, Inc. Deuterated heterocyclic gamma-carboline compounds and their use in the treatment or prophylaxis of a central nervous system disorder
JP2019510039A (ja) 2016-03-28 2019-04-11 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 新規組成物および方法
JP6997718B2 (ja) 2016-03-28 2022-01-18 イントラ－セルラー・セラピーズ・インコーポレイテッド 新規共結晶
JP2019513143A (ja) 2016-03-28 2019-05-23 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 新規塩類および結晶
CN110072518B (zh) 2016-10-12 2021-10-26 细胞内治疗公司 无定形固体分散体
JP6987868B2 (ja) 2016-12-29 2022-01-05 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
WO2018126140A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
MX2019011329A (es) 2017-03-24 2019-12-02 Intra Celular Therapies Inc Composiciones novedosas y metodos.
AU2018307479B2 (en) 2017-07-26 2024-06-20 Intra-Cellular Therapies, Inc. Organic compounds
IL272252B2 (en) 2017-07-26 2024-03-01 Intra Cellular Therapies Inc Transformed histories of gamma-carbolines fused with heterocyclics, pharmaceutical preparations containing them and their use for treatment
CA3102948A1 (en) 2018-06-08 2019-12-12 Intra-Cellular Therapies, Inc. Novel methods
KR20210031455A (ko) 2018-06-11 2021-03-19 인트라-셀룰라 써래피스, 인코퍼레이티드. 치환된 헤테로환 융합 감마-카르볼린 합성
MX2021002321A (es) 2018-08-31 2021-04-28 Intra Cellular Therapies Inc Nuevos metodos.
AU2019328528A1 (en) 2018-08-31 2021-03-18 Intra-Cellular Therapies, Inc. Novel methods
KR20220029744A (ko) 2019-07-07 2022-03-08 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규 방법
US11447479B2 (en) 2019-12-20 2022-09-20 Nuevolution A/S Compounds active towards nuclear receptors
WO2021198955A1 (en) 2020-03-31 2021-10-07 Nuevolution A/S Compounds active towards nuclear receptors
JP2023519605A (ja) 2020-03-31 2023-05-11 ヌエヴォリューション・アクティーゼルスカブ 核内受容体に対して活性な化合物
US11990584B2 (en) * 2020-11-10 2024-05-21 Lg Energy Solution, Ltd. Non-aqueous electrolyte solution for lithium secondary battery and lithium secondary battery including the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307087B1 (en) 1998-07-10 2001-10-23 Massachusetts Institute Of Technology Ligands for metals and improved metal-catalyzed processes based thereon
HN2000000203A (es) 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
US6759554B2 (en) 2001-04-24 2004-07-06 Massachusetts Institute Of Technology Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds

Also Published As

Publication number Publication date
JP2006514983A (ja) 2006-05-18
WO2004039788A1 (en) 2004-05-13
US20070049759A1 (en) 2007-03-01
AR041878A1 (es) 2005-06-01
US20040122226A1 (en) 2004-06-24
MXPA05004661A (es) 2005-06-08
TW200420547A (en) 2004-10-16
US7223870B2 (en) 2007-05-29
AU2003269414A1 (en) 2004-05-25
EP1562916A1 (en) 2005-08-17
CA2501314A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
BR0315888A (pt) Métodos para a preparação de oxazolidinonas n-ariladas via uma reação de acoplamento cruzada catalisada por cobre
TW200736895A (en) Power supply cooling system
CR10157A (es) Compuestos químicos
IL185494A0 (en) Purification of cinacalcet
CL2012000114A1 (es) Proceso para la preparacion de compuestos derivados de 5-amino-benzonorbornadieno donde se hacer reaccionar un compuesto de 5-halo-benzonorbornadieno con una bencilamina en prensecia de un catalizador de paladio.
IN2012DN00411A (pt)
SI1509517T1 (sl) Nova sinteza irbesartana
BRPI0601429A (pt) materiais dentários, que contêm compostos dendrìticos
TW200508219A (en) Process for preparing optically pure active compounds
ATE399775T1 (de) Triphenylethyleneverbindungen als selektive modulatoren des östrogenrezeptors
EA200702543A1 (ru) Циклопентадиенильно-флуоренильные лиганды с углеродными мостиками
MXPA03004986A (es) Proceso para preparar polimeros de emulsion con alta pureza.
HK1077827A1 (en) Diazabicyclononane and-decane derivatives their use as opioid receptor ligands
TW200510376A (en) Process for preparing (s)-pantoprazole
DE60314982D1 (de) Heftvorrichtung
SG148154A1 (en) Benzannelated compounds as ppar activators
NO20053208L (no) Metode for reduktiv dehalogenering.
BR0006843A (pt) Dispositivo de embreagem
ES2349654T8 (es) Purificación de compuestos de beta-lactama.
NO20053818L (no) Hydrogeneringskatalysator.
SE0501670L (sv) Tubhållare
ITCH20050004U1 (it) modulo di utilizzazione di fuido termovettore primario per l'alimentazione di utenze combinate.
MXPA05003881A (es) Preparacion de compuestos triazospiro.
ITBZ20040001A1 (it) Procedimento per il funzionamento di una trasmissione a frizione come pure trasmissione a frizione.
TW200700423A (en) Heterobicyclic acrylamides

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010.